SCHEMBL27223533

SCHEMBL27223533

CCOC(=O)c1[nH]ccc1NCc1ccc(Cl)cc1C1CCCCN1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 1/20 0.41
▸ KMT2A Q03164 2/20 0.38
▸ TSHR P16473 2/20 0.36
▸ MAPK1 P28482 2/20 0.36
▸ KDM4C Q9H3R0 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ MDM2 Q00987 1/20 0.36
▸ CASP3 P42574 2/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ LMNA P02545 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.35
▸ ALOX15 P16050 4/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ USP2 O75604 1/20 0.33
▸ MDM4 O15151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27224054 0.90 ALDH1A1 (0.45) F2KMT2ATSHRMAPK1RECQL
SCHEMBL30749308 0.90 ALDH1A1 (0.45) F2KMT2ATSHRMAPK1RECQL
SCHEMBL27224058 0.88 ALDH1A1 (0.39) KMT2AMAPK1CASP3HSD17B10KDM4E
SCHEMBL30028767 0.88 ALDH1A1 (0.47) F2KMT2ATSHRHSD17B10KDM4E
SCHEMBL27224083 0.88 ALDH1A1 (0.47) F2KMT2ATSHRHSD17B10KDM4E
SCHEMBL27224168 0.87 ALOX15 (0.39) KMT2AMAPK1CASP3HSD17B10KDM4E
SCHEMBL27224141 0.87 ALDH1A1 (0.38) F2TSHRMAPK1KDM4CMDM2
SCHEMBL27223361 0.82 OPRK1 (0.36) KMT2AMAPK1CASP3HSD17B10KDM4E
SCHEMBL30749326 0.79 ALDH1A1 (0.40) F2KMT2ATSHRMDM2MAPT
SCHEMBL30749295 0.79 ALOX15 (0.39) F2KMT2ATSHRHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240166642-A1 INHIBITORS OF MYELOPEROXIDASE ASTRAZENECA AB (SE) 2024-05-23 — — US disclosed
WO-2024038131-A1 INHIBITORS OF MYELOPEROXIDASE ASTRAZENECA AB (SE) 2024-02-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166642-A1 INHIBITORS OF MYELOPEROXIDASE MPO, XDH, EPX F2 73/4885KMT2A 3510/4885TSHR 1871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback